Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study

Journal of Neuro-Oncology

Volumn 101, Issue 2, 2011, Pages 267-277

  Mueller, Sabine ^a   Polley, Mei Yin ^a   Lee, Benjamin ^a   Kunwar, Sandeep ^a   Pedain, Christoph ^b   Wembacher Schröder, Eva ^b   Mittermeyer, Stephan ^b   Westphal, Manfred ^c   Sampson, John H ^d   Vogelbaum, Michael A ^e   Croteau, David ^f   Chang, Susan M ^a  

^a UNIVERSITY OF SAN FRANCISCO   (United States)

^b BRAINLAB AG   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f NeoPharm Inc   (United States)

Author keywords

Catheter scores; Convection enhanced delivery; Imaging; PRECISE study; Recurrent glioblastoma

Indexed keywords

CINTREDEKIN BESUDOTOX;

ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GRADING; CANCER SURVIVAL; CATHETERIZATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; GLIOBLASTOMA; HAZARD RATIO; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT ASSESSMENT; PROGRESSION FREE SURVIVAL; RECURRENT CANCER;

CATHETERS; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; EXOTOXINS; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-13; INTERNATIONAL COOPERATION; KARNOFSKY PERFORMANCE STATUS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78651338682     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0255-0     Document Type: Article

References (25)

1. R Stupp PY Dietrich S Ostermann Kraljevic A Pica I Maillard P Maeder R Meuli R Janzer G Pizzolato R Miralbell F Porchet L Regli N de Tribolet RO Mirimanoff S Leyvraz 2002 Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide J Clin Oncol 20 1375 1382 1:CAS:528: DC%2BD38XisVWmu7s%3D 10.1200/JCO.20.5.1375 11870182 (Pubitemid 34177445)
2. JH Sampson G Akabani GE Archer MS Berger RE Coleman AH Friedman HS Friedman K Greer JE Herndon 2nd S Kunwar RE McLendon A Paolino NA Petry JM Provenzale DA Reardon TZ Wong MR Zalutsky I Pastan DD Bigner 2008 Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors Neuro Oncol 10 320 329 1:CAS:528:DC%2BD1cXoslOrsbg%3D 10.1215/15228517-2008-012 18403491
3. MA Vogelbaum JH Sampson S Kunwar SM Chang M Shaffrey AL Asher FF Lang D Croteau K Parker AY Grahn JW Sherman SR Husain RK Puri 2008 Convection-enhanced delivery of cintredekin besudotox (interleukin-13-Pe38qqr) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results Neurosurgery 61 5 1031 1037 10.1227/01.neu.0000303199.77370.9e
4. W Debinski NI Obiri I Pastan RK Puri 1995 A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4 J Biol Chem 270 16775 16780 1:CAS:528:DyaK2MXmvFOktL8%3D 10.1074/jbc.270.15.8797 7622490
5. SR Husain BH Joshi RK Puri 2001 Interleukin-13 receptor as a unique target for anti-glioblastoma therapy Int J Cancer 92 168 175 1:CAS:528:DC%2BD3MXivVKqtrc%3D 10.1002/1097-0215(200102)9999:9999<::AID- IJC1182>3.0.CO;2-N 11291041 (Pubitemid 32225365)
6. BH Joshi GE Plautz RK Puri 2000 Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas Cancer Res 60 1168 1172 1:CAS:528:DC%2BD3cXhvFWrsLg%3D 10728667
7. H Liu BS Jacobs J Liu RA Prayson ML Estes GH Barnett BP Barna 2000 Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant glioma Cancer Immunol Immunother 49 319 324 1:CAS:528:DC%2BD3cXmtlSlsLo%3D 10.1007/s002620000110 10946814
8. JH Sampson R Raghavan ML Brady JM Provenzale JE Herndon 2nd D Croteau AH Friedman DA Reardon RE Coleman T Wong DD Bigner I Pastan MI Rodriguez-Ponce P Tanner R Puri C Pedain 2007 Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions Neuro Oncol 9 343 353 1:CAS:528:DC%2BD2sXpt1agtro%3D 10.1215/15228517-2007-007 17435179 (Pubitemid 47179574)
9. S Kunwar MD Prados SM Chang MS Berger FF Lang JM Piepmeier JH Sampson Z Ram PH Gutin RD Gibbons KD Aldape DJ Croteau JW Sherman RK Puri 2007 Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group J Clin Oncol 25 837 844 1:CAS:528:DC%2BD2sXjvVKmtLo%3D 10.1200/JCO.2006.08.1117 17327604 (Pubitemid 350002884)
10. IF Parney S Kunwar M McDermott M Berger M Prados S Cha D Croteau RK Puri SM Chang 2005 Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma J Neurosurg 102 267 275 1:CAS:528:DC%2BD2MXhslygs7g%3D 10.3171/jns.2005.102.2.0267 15739554
11. JH Sampson R Raghavan JM Provenzale D Croteau DA Reardon RE Coleman I Rodriguez Ponce I Pastan RK Puri C Pedain 2007 Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin AJR Am J Roentgenol 188 703 709 10.2214/AJR.06.0428 17312057
12. Kunwar S, Chang S, Westphal M, Vogelbaum M, Sampson J, Barnett G, Shaffrey M, Ram Z, Piepmeier J, Prados M, Croteau D, Pedain C, Leland P, Husain SR, Joshi BH, Puri RK, PRECISE Study Group (2010) Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol. doi: 10.1093/neuonc/nop054
13. R Raghavan ML Brady MI Rodriguez-Ponce A Hartlep C Pedain JH Sampson 2006 Convection-enhanced delivery of therapeutics for brain disease, and its optimization Neurosurg Focus 20 E12 10.3171/foc.2006.20.4.7 16709017
14. Sampson JH, Brady ML, Petry NA, Croteau D, Friedman AH, Friedman HS, Wong T, Bigner DD, Pastan I, Puri RK, Pedain C (2007) Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning. Neurosurgery 60:ONS89-98 (discussion ONS98-89)
15. Rabe-Hesketh S, Skrondal A (2005) Multilevel and longitudinal modeling using stata, 2nd edn. Stata Press, College Station
16. Therneau TM, Grambsch PM (2001) Modeling survival data: extending the Cox model, 1st edn. Springer, New York
17. Sampson JH, Archer G, Pedain C, Wembacher-Schroder E, Westphal M, Kunwar S, Vogelbaum MA, Coan A, Herndon JE, Raghavan R, Brady ML, Reardon DA, Friedman AH, Friedman HS, Rodriguez-Ponce MI, Chang SM, Mittermeyer S, Croteau D, Puri RK (2009) Poor drug distribution as a possible explanation for the results of the PRECISE trial. J Neurosurg
18. M Lacroix D Abi-Said DR Fourney ZL Gokaslan W Shi F DeMonte FF Lang IE McCutcheon SJ Hassenbusch E Holland K Hess C Michael D Miller R Sawaya 2001 A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival J Neurosurg 95 190 198 1:STN:280: DC%2BD38%2FlsFGitA%3D%3D 10.3171/jns.2001.95.2.0190 11780887
19. KR Lamborn WK Yung SM Chang PY Wen TF Cloughesy LM DeAngelis HI Robins FS Lieberman HA Fine KL Fink L Junck L Abrey MR Gilbert M Mehta JG Kuhn KD Aldape J Hibberts PM Peterson MD Prados 2008 Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas Neuro Oncol 10 162 170 10.1215/15228517-2007-062 18356283
20. PJ Dickinson RA LeCouteur RJ Higgins JR Bringas B Roberts RF Larson Y Yamashita M Krauze CO Noble D Drummond DB Kirpotin JW Park MS Berger KS Bankiewicz 2008 Canine model of convection-enhanced delivery of liposomes containing CPT-11 monitored with real-time magnetic resonance imaging: laboratory investigation J Neurosurg 108 989 998 1:CAS:528:DC%2BD1cXmtFSrsrs%3D 10.3171/JNS/2008/108/5/0989 18447717 (Pubitemid 351656848)
21. V Varenika P Dickinson J Bringas R LeCouteur R Higgins J Park M Fiandaca M Berger J Sampson K Bankiewicz 2008 Detection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery J Neurosurg 109 874 880 10.3171/JNS/2008/109/11/0874 18976077
22. W Debinski DM Gibo B Slagle SK Powers GY Gillespie 1999 Receptor for interleukin 13 is abundantly and specifically over-expressed in patients with glioblastoma multiforme Int J Oncol 15 481 486 1:CAS:528:DyaK1MXlsFynurw%3D 10427128
23. J Wykosky DM Gibo C Stanton W Debinski 2008 Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy Clin Cancer Res 14 1 199 208 1:CAS:528:DC%2BD1cXoslGn 10.1158/1078-0432.CCR-07-1990 18172271 (Pubitemid 351377996)
24. JS Jarboe KR Johnson Y Choi RR Lonser JK Park 2007 Expression of interleukin-13 receptor alpha2 in glioblastoma multiforme: implications for targeted therapies Cancer Res 67 7983 7986 1:CAS:528:DC%2BD2sXpvFKjt74%3D 10.1158/0008-5472.CAN-07-1493 17804706 (Pubitemid 47395129)
25. S Saikali T Avril B Collet A Hamlat JY Bansard B Drenou Y Guegan V Quillien 2007 Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy J Neurooncol 81 139 148 1:CAS:528:DC%2BD2sXitlyhsrk%3D 10.1007/s11060-006-9220-3 17004103 (Pubitemid 44963972)